Orphan designation: Interleukin-12, human, recombinant Treatment of cutaneous T-cell lymphoma, 10/11/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 November 2024 - 12:43

Orphan designation: Interleukin-12, human, recombinant Treatment of cutaneous T-cell lymphoma, 10/11/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-2983

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters